financetom
Business
financetom
/
Business
/
Healwell AI to Raise $16 Million in Bought Deal Private Placement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Healwell AI to Raise $16 Million in Bought Deal Private Placement
May 6, 2024 5:53 AM

08:41 AM EDT, 05/06/2024 (MT Newswires) -- Healwell AI (AIDX.TO), an AI and data science company, on Monday said it will raise $16 million in a bought deal private placement that will fund growth initiatives and provide general working capital.

The company will issue 11.8 million units, at $1.35 each. Each unit will be comprised of one Class A subordinate voting share and half a share purchase warrant. Each warrant is exercisable for two years for one share at $1.80.

The underwriters have been granted a 15% over-allotment option, which, if exercised in full, will yield an additional $2.4 million, bringing the total proceeds to $18.4 million.

The offering is expected to close about May 24.

Healwell closed 5.6% lower on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neurosense Therapeutics Shares Up After Initial Phase 2 Data of Alzheimer's Disease Treatment Show Enhanced Neuroplasticity
Neurosense Therapeutics Shares Up After Initial Phase 2 Data of Alzheimer's Disease Treatment Show Enhanced Neuroplasticity
Sep 10, 2025
03:01 PM EDT, 09/10/2025 (MT Newswires) -- Neurosense Therapeutics ( NRSN ) shares rose more than 39% in recent Wednesday trading after the initial phase 2 trial results of PrimeC to treat Alzheimer's disease showed enhanced neuroplasticity and no treatment-related toxicity. Neuroplasticity is an important feature in supporting brain health and function. The trial in collaboration with NeuroKaire is designed...
Market Chatter: AppLovin Sees Short Interest Rise, Reversing Decline Seen Earlier in 2025
Market Chatter: AppLovin Sees Short Interest Rise, Reversing Decline Seen Earlier in 2025
Sep 10, 2025
03:10 PM EDT, 09/10/2025 (MT Newswires) -- Short interest in AppLovin ( APP ) is rising again, even after traders betting against the ad-tech firm suffered an estimated $3.4 billion in paper losses over the past six months, Bloomberg reported Wednesday. According to the report, data from S3 Partners showed that shares borrowed and sold short climbed this week to...
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients
Sep 10, 2025
BioXcel Therapeutics, Inc ( BTAI ). on Wednesday released topline exploratory efficacy data from the SERENITY At-Home Pivotal Phase 3 safety trial, which demonstrated that BXCL501 had continued effects and consistent benefit with repeat dosing. The trial in the home setting evaluated a 120 mcg dose of BXCL501, the company’s proprietary, sublingual film formulation of dexmedetomidine, Igalmi, for agitation associated...
US State Dept OKs possible sale of air-to-air missiles to Finland for $1.07 billion
US State Dept OKs possible sale of air-to-air missiles to Finland for $1.07 billion
Sep 10, 2025
Sept 10 (Reuters) - The U.S. State Department has approved a potential sale of AIM-120D-3 advanced medium range air-to-air missiles and related equipment to Finland for $1.07 billion, the Pentagon said on Wednesday. The principal contractor for the sale is RTX Corp ( RTX ), the Pentagon said. (Reporting by Ryan Patrick Jones in Toronto) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved